BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17.03.2003

Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use; Correction

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 6, 2003 (68 FR 6062). The document amended FDA's regulations to require that the labeling for all systemic antibacterial drug products intended for human use include certain statements about using antibiotics in a way that will reduce the development of drug-resistant bacterial strains. The document was published with an inadvertent error. This document corrects that error.

Source: Federal Register — Food and Drug AdministrationOpen original release →